Clinical pharmacologic study of kethoxal bis(thiosemicarbazone) [NSC-82116] in advanced cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013882:Thiosemicarbazones / Q000008:administration & dosage* / Q000009:adverse effects*
D000970:Antineoplastic Agents; D013882:Thiosemicarbazones